Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311311 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Herena Eixarch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebro…. Hauptthemen laut MEDLINE: Cladribine, Oxidative Stress, Central Nervous System, Neuroprotective Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck KGaA.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a chronic neuroinflammatory and demyelinating disease that causes disability in patients. Cladribine is an oral treatment that is used in relapsing–remitting and active secondary progressive MS. T and B lymphocytes are especially sensitive to cladribine, which are transiently depleted upon short treatment courses. However, cladribine crosses the blood–brain barrier (BBB), supporting the hypothesis that cladribine may affect central nervous system (CNS)-resident cells. In this study, we used human primary cells and human cell lines to test the effect of cladribine, at therapeutic concentrations, on cells of the CNS. In these conditions, cladribine did not affect survival, proliferation and the capacity of producing cytokines of human microglial cells (HMC3 cell line) or primary human astrocytes but enhanced the production of oxygen reactive species in both cell types. The initial differentiation of primary human neuronal progenitor cells was impaired when continuously exposed to the maximum therapeutic concentration of cladribine, but not when lower concentrations were used. However, cladribine protected differentiated SH-SY5Y human neuroblastoma cell line from oxidative stress-related cell death. In conclusion, using different in vitro cell models, we demonstrate that cladribine maintains the normal function of CNS glia and protects neuronal cells from oxidative stress damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
- Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, 28031 Madrid, Spain.
- Merck Healthcare KGaA, F135/002, 64293 Darmstadt, Germany.
ORCID-Profile: Herena Eixarch, Laura Calvo-Barreiro, Nicolás Fissolo, Arnau Hervera, Manuel Comabella, Xavier Montalban, Carmen Espejo
Förderung
- Merck KGaA
Zitieren
APA
Eixarch, H., Calvo-Barreiro, L., Fissolo, N., Boschert, U., Hervera, A., Comabella, M., Montalban, X., & Espejo, C. (2025). Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311311
Vancouver
Eixarch H, Calvo-Barreiro L, Fissolo N, Boschert U, Hervera A, Comabella M, et al. Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311311
BibTeX
@article{Eixarch2025,
author = {Eixarch, Herena and Calvo-Barreiro, Laura and Fissolo, Nicolás and Boschert, Ursula and Hervera, Arnau and Comabella, Manuel and Montalban, Xavier and Espejo, Carmen},
title = {Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311311}
}
EUVIMED